Scientific Advisory Board
Our Scientific Advisory Board provides strategic guidance and direction that benefits the quality of the scientific research carried out at the Princess Máxima Center. Integrating care and research means that the scientific discoveries can be directly applied to the treatment of childhood cancer patients.
The Scientific Advisory Board advises the Board of Directors of the Princess Máxima Center on setting up the research program, the infrastructure, and strategic partnerships for research. The Board consists (inter)national members who have been asked to join on the basis of their exceptional knowledge and expertise in (pediatric) oncology research.
The Scientific Advisory Board of the Princess Máxima Center consists of the following distinguished members:
Prof. Dr. Martin Eilers (Chair) - Tumorgenese, University of Würzburg, Biocenter, Würzburg, Duitsland
Prof. Dr. Ton Schumacher (Co-chair) - Kanker Immunologie, Nederlands Kanker Instituut, Amsterdam, Nederland
Prof. Dr. Richard Gilbertson - Cellulaire en moleculaire oorsprong van kanker, University of Cambridge, Cambridge, GB
Prof. Dr. Anton Henssen - Centrum voor experimenteel en klinisch onderzoek, Max Delbrück Center (MDC) and Charité University Hospital Berlin, Berlijn, Duitsland
Prof. Dr. Anne May - Klinische epidemiologie van kanker, UMC Utrecht, Utrecht, Nederland
Dr. Julie Park - Ontwikkelings- en translationeel onderzoek naar kanker bij kinderen, St. Jude Children’s Research Hospital, Memphis, TN, VS
Prof. Dr. Kimberley Stegmaier - Kankergenomica, Dana Farber Cancer Institute, Boston, MA, VS